Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1982-02-19
1985-05-28
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
514 8, A61K 3944, A61K 39395, A61K 4505
Patent
active
045200114
ABSTRACT:
The rate of protein synthesis inhibition is significantly increased by adding excess ricin B chain to target cells independent of the amount of ricin A chain bound to the cell surface membrane. Ricin is a known toxin from albumin of the castor oil bean and contains an A chain and a B chain for binding to receptors. The present invention is concerned with ricin hybrids such as OX-7-ricin A chain and 19E12-F(ab) ricin A chain which were produced by conjugation of the ricin A chains with anti-Thy 1.1 monoclonal antibodies. The conjugates were utilized in pharmaceutical amounts in mice.
REFERENCES:
patent: 4356117 (1982-10-01), Neville et al.
patent: 4359457 (1982-11-01), Neville, Jr. et al.
patent: 4397843 (1983-08-01), Neville et al.
Youle et al., Proc. Natl. Acad. Sci., U.S.A., vol. 77, No. 9, pp. 5483-5486 (1980).
Masuho et al., Biochem. Biophys. Res. Comm., 90: 320-326 (1979).
Neville/Youle, Immunology Reviews, vol. 62, p. 135, 1981.
Vallera et al., "Bone Marrow Transplantation Across Major Histocompatibility Barriers".
Neville Jr. David M.
Youle Richard J.
Roberts, Jr. John S.
Rose Shep K.
The United States of America as represented by the Department of
LandOfFree
Inactivating protein synthesis by incubating anti-Thy 1.1-ricin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivating protein synthesis by incubating anti-Thy 1.1-ricin , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivating protein synthesis by incubating anti-Thy 1.1-ricin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-868377